Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report

Abstract Background For people with opioid use disorder who are not responding to oral opioid agonist treatment, evidence supports the effectiveness of injectable opioid agonist treatment with injectable hydromorphone (an opioid analgesic) and diacetylmorphine (pharmaceutical grade heroin). While th...

Full description

Bibliographic Details
Main Authors: Heather Palis, Scott MacDonald, Jennifer Jun, Eugenia Oviedo-Joekes
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Harm Reduction Journal
Subjects:
Case report
Stimulant use disorder
Opioid use disorder
Pharmacological treatment
Dextroamphetamine
Cocaine
Online Access:https://doi.org/10.1186/s12954-021-00500-9

Similar Items

Similar Items